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Cambridge, UKABSTRACT Emphysema and liver cirrhosis can be caused by the Z mutation (Glu342Lys) in the serine protease inhibitor a1-
antitrypsin (a1AT), which is found in more than 4% of the Northern European population. Homozygotes experience deficiency in
the lung concomitantly with a massive accumulation of polymers within hepatocytes, causing their destruction. Recently, it was
proposed that Z-a1AT polymerizes by a C-terminal domain swap. In this study, small-angle x-ray scattering (SAXS) was used to
characterize Z-a1AT polymers in solution. The data show that the Z-a1AT trimer, tetramer, and pentamer all form ring-like struc-
tures in strong support of a common domain-swap polymerization mechanism that can lead to self-terminating polymers.INTRODUCTIONa-1-Antitrypsin (a1AT) is an ~50 kDa acute-phase glyco-
protein that is synthesized by hepatocytes and secreted
into the circulation, where it is found at 1.5–3.5 g/L (1,2).
Its role is to inhibit proteases secreted by inflammatory cells
and its primary target protease is neutrophil elastase (for a
review, see Gettins (3)). a-1AT is a member of the serine
protease inhibitor (Serpin) superfamily of proteins. As an
inhibitory serpin, a1AT circulates in a metastable native
state with the main b-sheet A in a five-stranded form
(Fig. 1 A, red), and a protease target site located on a ~20
residue solvent-exposed and unstructured reactive center
loop (RCL; Fig. 1 A, yellow). Cleavage of the RCL by the
target protease leads to a marked conformational change
whereby the N-terminal part of the RCL rapidly inserts
into the center of b-sheet A, dragging along the ester-
bonded protease to its ultimate inactivation by active-site
distortion at the opposite pole of the serpin molecule
(Fig. 1 B). The resulting hyperstable serpin-protease com-
plex can subsequently be cleared from the extracellular
space (4,5). This mechanism is thermodynamically driven
with ~32 kcal/mol of free energy released by the formation
of a six-stranded b-sheet A in the final complex (Fig. 1 B,
red/yellow) (6,7). An inherent problem with this mechanism
is the requirement of a serpin to fold into a metastable native
state rather than the state with the lowest free-energy term
predicted by the Anfinsen principle (8). This means that
the serpin is susceptible to point mutations, which can
lead to misfolding and disease. Point mutations in other ser-Submitted February 4, 2014, and accepted for publication August 26, 2014.
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0006-3495/14/10/1905/8 $2.00pins, such as antithrombin, C1-inhibitor, and neuroserpin,
have been shown to lead to thrombosis, angioedema, and de-
mentia, respectively (for a review, see Gooptu and Lomas
(9)).
In a1AT, the most common disease-causing variant is the
Z mutation (Glu342Lys), which is carried by ~4% of North-
ern Europeans. Homozygous ZZ individuals (~1 in 1700)
have 10–15% of the normal circulating levels of a1AT, re-
sulting in serious deficiency, which can lead to pulmonary
emphysema and chronic obstructive pulmonary disorder
(COPD) due to excessive elastase activity in the lungs
(10–13). This deficiency is caused by misfolding within
the endoplasmic reticulum of synthesizing cells, and these
misfolded proteins accumulate as polymers (14,15). The re-
sulting toxicity can lead to cirrhosis, neonatal hepatitis, and
hepatocellular carcinoma (16–18).
In patient samples, polymers of a1AT can be observed as
long chains in what has become known as a beads-on-a-
string morphology (19). As in the final serpin complex,
polymers are hyperstable and the reactive center loop is
resistant to proteolytic cleavage, supporting the same type
of insertion as in the inhibitory complex. Electron micro-
scopy has shown that there appears to be marked flexibility
in the linker region between protomers, as some protomers
can be observed at 90 relative to each other. Additionally,
some polymers can be seen to form necklace-like structures
or circlets, indicating that the loose donor and acceptor ends
of the serpin chains are complementary and able to couple
together to create self-terminating entities (19). These
closed polymer forms can no longer incorporate new proto-
mers, making them stable and thus suitable molecules for
structural studies (20–23).http://dx.doi.org/10.1016/j.bpj.2014.08.030
FIGURE 1 Proposed mechanisms of a1AT
polymerization. The structural features of a1AT
in several conformations are displayed. (A–E)
The central b-sheet A is highlighted in red and
the RCL/s4A is colored yellow in both native (A)
and complexed (B) a1AT, and in the first protomer
of each polymer type (C–E). (A) The native struc-
ture of a1AT (PDB ID: 1QLP) (55) with additional
color labeling of b-sheets B (light blue) and C
(green). The individual strand numbers of the three
b-sheets are shown. The intact RCL is unstructured
and presents the scissile bond (P1–P10 residues
shown as purple spheres) as a pseudo-substrate
for the target protease. b-sheet A contains only
five strands with neighboring strands 3A and 5A
parallel to each other. a-Helices are labeled h#,
where # is a letter from A to I. (B) Crystal structure
of the a1AT-trypsin complex (PDB ID: 1EZX) (4).
The protease is shown in green. This structure
shows the final serpin-protease complex formed
by translocation and inhibition of the protease.
The cleaved RCL is fully inserted into b-sheet A
as strand 4A. (C) Loop-sheet mechanism of serpin
polymerization. The current model of the loop-
sheet A linkage involves the insertion of P8-P3 res-
idues from the RCL of one serpin molecule into the
b-sheet A of another (9,56). There is a gap at the
top of the s4A position to allow presentation of
the RCL. The model comes from a modeling study
by Huntington and Whisstock (54). (D) The s4A/
5A polymerization mechanism model was gener-
ated from PDB ID 2ZNH (22). The intermolecular
linkage between protomers involves a domain
swap of >50 residues with both s5A and s4A/
RCL of one protomer (red/yellow) inserted into
the b-sheet A of a second protomer (shown in
green). Each resulting protomer therefore has a
six-stranded b-sheet A. (E) C-terminal domain-
swap polymerization model generated from PDB
ID 3T1P (23). The domain swap involves the last
three C-terminal b-strands (s1C, s5B, and s4B).
The RCL of each protomer is inserted into its
own b-sheet A and is not involved in the domain
swap. A second serpin protomer is shown in green.
1906 Behrens et al.The limited availability of patient plasma and the mixed
nature of the polymeric material obtained place limitations
on a more detailed molecular analysis of polymeric struc-
tures from this material. However, native plasma or re-
combinant serpins can be induced to form polymers by
incubation at elevated temperatures (21,24,25), at low pH
(22,26,27), or in the presence of low concentrations of cha-
otropic reagents such as urea (28), guanidine hydrochloride
(21,22,29), and SDS (30,31). Like polymers extracted from
liver cells, these in vitro polymers form a characteristic lad-
dering pattern on native PAGE (30,32). The finding that an
RCL peptide could prevent the in vitro polymer formation of
native a1AT led to the loop-sheet hypothesis, which pro-
poses that the intact RCL of one serpin inserts into the center
of b-sheet A of another serpin as strand 4A (25,29,33).Biophysical Journal 107(8) 1905–1912Although a number of crystal structures of an RCL-cleaved
a1AT polymer and native or near-native serpins with and
without small peptides have been presented, no structure
of an intact loop-sheet polymer has been published to date
(9,34–38).
Recently, two crystal structures of closed serpin polymers,
each demonstrating polymerization by novel domain-swap
mechanisms, were published (22,23). In the first structure,
a dimer of a related serpin antithrombin was produced
from native plasma-derived material by heating to 37C at
low pH (22). The protomers were linked by an ~50 residue
domain swap involving not just the RCL but also the neigh-
boring b-strand 5A (s5A; Fig. 1 D). Disulphide trapping,
fluorescent labeling, and limited proteolysis studies with
a1AT suggested that this may also be the mechanism by
Z-a1AT Polymers in Solution 1907which Z-a1AT forms polymers, leading to what was termed
the s4A/5A domain-swap hypothesis (22). In a subsequent
study using a variant of a1AT in which s4A/5A domain
swapping was prevented with a disulphide bond, Yamasaki
et al. (23) formed different polymers using high tempera-
tures. These polymers were crystallized as a trimer linked
by a C-terminal domain-swap involving s1C, s4B, and s5B
(Fig. 1 E). The RCL of each protomer was inserted into b-
sheet A, but was not involved in the domain swap. This led
to what was termed the C-terminal domain-swap hypothesis.
The C-terminal domain-swap mechanism agreed well with a
concurrent study in which an elaborate folding pathway for
a1AT was elegantly proposed (39). The final critical step
of folding was proposed to be the insertion of the C-terminal
domain-swapping region as observed in the trimer crystal
structure, ensuring that the native meta-stable conformation
(Fig. 1 A), and not the thermodynamically more stable RCL-
inserted inactive form (Fig. 1 B), is reached.
Testing serpin polymerization hypotheses using patho-
genic serpin variants has been difficult due to the lack of a
recombinant source of Z-a1AT. However, recent work has
demonstrated that small amounts of Z-a1AT can be purified
from the methylotrophic yeast species Pichia pastoris (40).
Yeast-derived native Z-a1AT appears to behave similarly to
material purified from patient plasma (41,42). Additionally,
as in liver cells, the Z mutation causes misfolding during
protein expression, leading to Z-a1AT polymer formation
within the cytosol (40). Using purified Z-a1AT polymers,
we sought to investigate which of these three proposed
mechanisms underlies the polymerization of Z-a1AT
in vivo. To do this, we had to extend the structural character-
ization of Z-a1AT polymers beyond what is obtainable by
the structural approaches of NMR or protein crystallog-
raphy. To examine the mechanism of spontaneous Z-a1AT
polymerization under physiological conditions, we em-
ployed small-angle x-ray scattering (SAXS), a solution-
based structural technique in which the solution conditions
can easily be varied. Whereas crystal structures provide
static atomic-resolution models, SAXS can give the overall
shape and thus produce low-resolution molecular models of
proteins in solution (43). From our study, we conclude that
the Z-a1AT trimer in solution is indeed similar to the one
observed in the protein crystal. Furthermore, the tetramer
and pentamer polymers both follow the circular pattern, in
strong support of a common C-terminal domain-swapping
mechanism of polymerization. Our work may facilitate ef-
forts to control Z-a1AT polymerization with the aim of hin-
dering the pathology associated with in vivo accumulation.MATERIALS AND METHODS
Sample preparation
Full-length a1AT (1-392) containing the Z mutation (Glu342Lys) in the
pHILD2 vector was a kind gift from Prof. Steve Bottomley (Monash Uni-versity, Australia). The single endogenous cysteine (residue 232) was
mutated to a serine by site-directed mutagenesis (Agilent Technologies,
Santa Clara, CA). The resulting construct was linearized by a SacI diges-
tion and incorporated into the genome of the methylotrophic yeast species
P. pastoris via homologous recombination at the AOX1 locus as previ-
ously described (40,44). In these stably transformed cells, expressed
Z-a1AT remains within the cytosol (44). After an initial growth phase
of 48 h in YP medium containing D-glucose as a nutrient source,
Z-a1AT expression was initiated by the replacement of D-glucose with
methanol. After a further 72 h of expression, the cells were harvested
and lysed using a cell disruptor. Initially, Z-a1AT was purified from the
crude lysate by nickel affinity chromatography via its N-terminal polyhis-
tidine tag using a HiTrap IMAC HP column (GE Healthcare). Subse-
quently, an NaCl gradient on a HiTrap Q HP Sepharose column (GE
Healthcare) was used to separate monomeric, short, and long polymeric
forms of Z-a1AT as previously described (40). Fractions containing short
polymer were pooled, concentrated to 40 mg/ml using a spin concentrator
(Vivaspin 10,000 MWCO; Sartorius Stedim Biotech), and loaded onto a
HiLoad 16/60 Superdex column (GE Healthcare). Individual oligomeric
species eluted as separate peaks (Fig. S1 in the Supporting Material, red
trace). Fractions containing trimeric Z-a1AT protein were pooled, concen-
trated, and rerun on the size-exclusion column. This process was repeated
until material of high purity was observed by native PAGE analysis (See
Fig. 4, Fig. S1, purple trace, and Fig. S3, lane 2). Tetramer and pentamer
were purified in a similar fashion (See Fig. 4, Fig. S1, blue and green
traces, and Fig. S3, lanes 3 and 4). Each sample was then concentrated
and frozen at 80C in standard PBS buffer. Samples for SAXS were pre-
pared by dilution into the matching PBS buffer to concentrations of 0.3,
1.5, and 1.5 mg/ml of trimer, tetramer, and pentamer, respectively. Protein
concentrations were determined from optical density at 280 nm using a
nanodrop spectrophotometer.Instrumentation and data collection
SAXS data were collected on a laboratory-based instrument at iNANO,
Aarhus University, Denmark (45). This instrument has a two-pinhole setup
in which the second pinhole, situated immediately in front of the sample, is
an in-house-built scatterless pinhole, which for the rotating anode and x-ray
optics employed here gives a flux of 3  108 counts s1. The instrumental
sample-to-detector distance was set to 640 cm, giving a q range of
0.01–0.345 A˚1, where q is the length of the scattering vector, defined as
q ¼ 4p sinðqÞ=l, where l is the x-ray wavelength at 1.54 A˚, and 2q is the
scattering angle between the incident and scattered beam. The instrument
uses a two-dimensional position sensitive gas detector (HiSTAR) and the
recorded data were corrected for variation in detector sensitivity and distor-
tion according to standard procedures (45). The samples and matching
buffers were placed in reusable quartz capillaries held in a thermostated
block and the temperature was maintained at 25C. The acquisition times
were 14,400 s, 10,800 s, and 28,800 s for the trimer, tetramer, and pentamer,
respectively. Purified serpin polymers are hyperstable (20) and cannot inter-
convert to other polymer types once they are formed. When the polymers
were heated at temperatures up to 50C, no evidence of interconversion
was observed (data not shown). All corresponding buffers were collected
for the same amount of time as the samples. Background buffer subtraction
and conversion of the data to absolute scale by using water as the primary
standard were performed using the SUPERSAXS program package
(J.S.P. and C.L.P. Oliveira, unpublished). The final intensity is I(q) in units
of cm1.Data analysis and ab initio shape determination
Indirect Fourier transformation (IFT) analysis was performed using the pro-
gram WIFT (46) (J.S.P. and C.L.P. Oliveira, unpublished) to obtain the pair
distance distribution function, p(r), along with the characteristic parametersBiophysical Journal 107(8) 1905–1912
1908 Behrens et al.(the maximum diameter, Dmax; the radius of gyration, Rg; and the forward
scattering, I(q ¼ 0)). The Rg for the three oligomers was also determined
using the Guinier approximation, and similar values were obtained. The
Guinier plots and corresponding Rg are included in Fig. S2 and Table 1.
The linear behavior of the data in the Guinier region is a good indication
of homogeneous samples without aggregation. The molecular mass, Mw,
of the scattering protein can be determined from I(q ¼ 0) as
Mw ¼ Iðq ¼ 0Þ=fDr2mcg, where c is the protein concentration given as
mass per volume and Dr2m is the scattering length density difference per
unit mass. The value for the scattering length density was determined
from the scattering data of the trimer (Drm¼ 1.7 1010 cm/g), as the trimer
is known from size-exclusion chromatography and native PAGE to be a
monodispersed sample (see Figs. 4 and S1). To obtain a structural model
of the scattering molecule in solution without the use of any assumptions
other than Dmax, we performed ab initio modeling using the program
DAMMIN (47). It should be noted that when this method is used to obtain
the overall shape of the macromolecule in solution, cavities in the structure
may be difficult to resolve (48) and artifacts may occur, such as twisting of
the structure or openings in a ring-like structure. Due to the Monte-Carlo-
like nature of the ab initio modeling approach, the solutions are nonunique;
therefore, we obtained 10 individual models and subsequently compared
and averaged them by using the program package DAMAVER (48). A sim-
ilarity measure, the normalized spatial discrepancy (NSD), was obtained
using this procedure. The NSD matrix also allows the discrimination and
grouping of possible subsets of models.Rigid-body structure modeling and model
comparisons
An atomic-resolution structure model is available for the Z-a1AT trimer
(PDB ID: 3T1P). To evaluate the similarity between the crystal structure
and the solution structure, we computed the theoretical scattering profile
of the model with atomic resolution and compared it with the experimental
data using the program CRYSOL (49). To further investigate the structure
of Z-a1AT oligomers (as trimer, tetramer, or pentamer), we performed
rigid-body modeling using the program SASREF (50). Here, the appro-
priate number of atomic-resolution monomer subunits (PDB ID: 3T1P)
was restricted to ensure a separation of no more than 20 A˚ between Asn-
367 in one monomer and Arg-358 in the subsequent monomer. The distance
constraint was chosen on the basis of the crystal structure model as the
maximum allowed covalent length of the intermonomer linker (3.5 A˚ per
amino acid). Relaxing the linker distance constraint to 30 A˚ or using no re-
straint yielded similar solutions, although the head-tail orientation was not
uniformly maintained. Since the rigid-body models obtained with SASREF
are nonunique, we generated a minimum of 10 individual models and
compared them using part of the DAMAVER program package, specifically
the programs SUPCOMB (51) and DAMSEL (48). The most representative
rigid-body model (i.e., best representing the average of the population) was
found during averaging. All structures and ab initio model views were pre-TABLE 1 Calculated SAXS parameters
Sample Mw [kDa]
a Mwteo [kDa]
b Rg [A˚]
c Dmax [A˚]
d
Trimer — 140 36 5 1 1005 10
Tetramer 1795 27 188 46 5 1 1305 10
Pentamer 2785 56 235 56 5 1 1605 10
aThe molecular mass estimated by IFT from the forward scattering (I(q ¼ 0)) a
bThe theoretical molecular mass of the polymer.
cThe calculated ratio of gyration (Rg) from IFT.
dThe calculated Dmax from IFT.
eThe c2 fit quality of the ab initio modeling to the scattering data.
fThe NDS values of the fit of the rigid-body modeling to the ab initio envelope
Biophysical Journal 107(8) 1905–1912pared using PyMOL (PyMOLMolecular Graphics System, version 1.5.0.4;
Schro¨dinger, LLC.).RESULTS
The soluble Z-a1AT trimer is similar to the protein
crystal model
Based on the structural model available from protein crys-
tallography, we decided to initiate our SAXS study by inves-
tigating the Z-a1AT trimer in solution. This would establish
the basis for subsequent analyses of higher-order Z-a1AT
polymers and link our results to conclusions regarding
a1AT polymerization based on existing structural studies.
From IFT of the SAXS data (Fig. 2 A), we obtained Dmax
(the largest dimension in the studied molecules, which is
frequently referred to as the largest diameter) while calcu-
lating the pair distance distribution function, p(r). The p(r)
function is a histogram of internal distances for pairs of
points weighted by the excess electron densities at the
points, and thus this function relates to the structure of the
particle (Fig. 2 B).
When we compare the Dmax of 100 A˚ (Table 1) with the
overall dimensions of the a1AT monomer (~40  70 A˚ as
measured in the available crystal structures), it is immedi-
ately evident that the trimer must be compact. This is also
supported by the p(r) function, which resembles that of
ring-like structures with high values at short and longer dis-
tances. The first peak at short distances is shifted to the left
of Dmax/2, which corresponds to distances within the short
dimension of the ring (thickness of the ring ~ width of the
protomer). The peak at large distances is at the maximum
of the p(r) function shifted to the right of Dmax/2 and corre-
sponds to the longer distances (between protomers) across
the ring (52). Interestingly, the atomic-resolution model of
the Z-a1AT trimer was able to reasonably predict the exper-
imental scattering data with c2 ¼ 6.3 (Table 1 and Fig. 2 C).
Thus, the overall shape of the Z-a1AT trimer in solution
must be close to what is observed in the protein crystal struc-
ture (for a visual presentation, see Fig. S3). To investigate
the overall molecular shape of the trimer, we obtained an
ab initio (no prior knowledge) envelope from the SAXSFit quality, c2e Fit quality, c2e NSDf
CRYSOL DAMMIN/SASREF
6.3 1.6/4.4 1.1 5 0.02/0.95 0.07
— 1.3/2.4 0.6 5 0.02/1.25 0.07
— 0.9/3.6 1.1 5 0.05/1.35 0.13
t the indicated sample concentration.
.
FIGURE 2 SAXS data and fits. Scattering data were collected for the trimer (open triangles), tetramer (open squares), and pentamer (open diamonds). (A)
Scattering data overlaid with the respective indirect Fourier transform fits (black curves). (B) The resulting p(r) functions of the trimer (black curve), tetramer
(gray curve), and pentamer (broken black curve). (C) Scattering data with the rigid-body model fit of the most representative rigid-body model (black line)
and CRYSOL fit of protein crystal structure to the trimer data (gray curve). In panels A and C, the scattering data and fits are offset by 101, 10, and 101 for
trimer, tetramer, and pentamer, respectively, to improve the visualization.
Z-a1AT Polymers in Solution 1909data (Fig. 2 B). Ten individual ab initio models were gener-
ated without symmetry restraints and subsequently were
mutually compared and averaged. Because all of the models
were similar, with an NSD value of 1.1 (Table 1), the
average model could be used to describe the trimer in solu-
tion (Fig. 3 A). Although the envelope has low resolution, it
describes the overall quaternary structure of the polymer.
The trimer envelope exhibits a toroidal shape with dimen-
sions of ~90  90  35 A˚, which correspond well with
the dimensions of the atomic-resolution structure. We
derived a structural model of the trimer that best fit the
experimental data using rigid-body modeling, again with
no fixed symmetry. A comparison of 10 solutions showed
that all models were similar, with an NSD of 0.9, indicating
that there was only one dominant solution. The fit quality of
the most representative rigid-body model (best representing
the average) to the scattering data (Fig. 2 C) was improvedas compared with the crystal structure model, with a c2 of
4.4 vs. 6.3. A comparison of the most representative rigid-
body model and crystal structures reveals a small difference:
the crystal structure is symmetric, whereas in the most
representative rigid-body model, the triangular polymer is
squeezed into a slightly elongated shape (Fig. S3). The over-
all similarity, however, suggests that the crystal structure is
still a good representation of the trimer in solution.The Z-a1AT tetramer adopts a ring-like quaternary
structure
Next, we increased the complexity by analyzing the Z-a1AT
tetramer. Since no crystal structure is available for the
tetramer, ab initio modeling was a necessary first step to
evaluate the data after IFT analysis. It was evident from
the IFTanalysis that the tetramer has aDmax of 130 A˚, whichFIGURE 3 Ab initio envelopes with representa-
tive structure models. Ab initio envelopes derived
from the scattering data are shown in transparent
gray, representing the molecular shapes of trimer
(column A), tetramer (column B), and pentamer
(column C), respectively. The envelopes are drawn
to scale. The envelopes are overlaid with the
respective most representative rigid-body model
(shown in blue cartoon). The lower panel is similar
to the top panel, rotated 90 around the horizontal
axis. A schematic drawing of each polymer is
shown at the top of each column, representing
the common C-terminal Z-a1AT domain-swap
polymerization mechanism as suggested by our
work. The black scale bar (bottom-left corner)
represents 100 A˚. Figures were prepared using
PyMOL (PyMOL Molecular Graphics System,
version 1.5.0.4 Schro¨dinger, LLC; for rendering
details, see the legend of Fig. S4).
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Fig. 2 A). This modest increase in Dmax after the addition
of one more monomer supports a compact quaternary struc-
ture of the tetramer. The maximum value of the p(r) function
(Fig. 2 B) of the tetramer had an even more pronounced shift
to the right of Dmax/2 as compared with the trimer, indi-
cating that the overall dimension (diameter) of the ring is
increasing. However, the first peak does not change position,
indicating that the distance covering the thickness of the
ring has not changed. This is expected, as the dimensions
of the protomers making up the polymers are the same.
The 10 ab initio models are similar and the average model
fits the experimental data well (Table 1 and Fig. 2 A). Strik-
ingly, the average ab initio envelope exhibits a well-defined
circular-shaped, ring-like structure (Fig. 3 B), supportive of
a simple one-protomer addition to the observed circular
shape of the trimer. To test whether a domain-swap tetra-
meric model could indeed reproduce the scattering data,
we used a similar rigid-body modeling procedure employ-
ing the same loose head-to-tail restraints as used for the
trimer. The 10 individual solutions were found to be similar,
with an NSD value of 1.2, and the most representative rigid-
body model fit the scattering data well, with a c2 value of 2.4
(Table 1 and Fig. 2 C). In summary, our tetramer structure
model strongly supports the proposed C-terminal domain-
swap model, in which a mutual domain swap among four
Z-a1AT molecules forms a near-perfect ring-like structure
(Fig. 3 B).The Z-a1AT pentamer data support a common
mechanism of polymerization
We performed a similar and complete analysis on the puri-
fied pentamer, the largest polymer obtainable in suitable
amounts by our purification procedure. As in the case of
the tetramer, the estimated mass increase corresponded to
the expected polymer size (Table 1). Again, there was a
modest increase in Dmax to 160 A˚ (Table 1), suggesting a
compact overall structure. The data showed no sign of ag-
gregation (i.e., no upturn at low q), in agreement with a sta-
ble and homogeneous polymer sample (Figs. 2 A and S1).
The p(r) for the pentamer is similar to the trimer and
tetramer p(r), suggesting that the shape of the macromole-
cule is ring-like with an increase of the overall diameter
of the ring, as the second maximum has moved to longer
distances. Furthermore, the first maximum is conserved
compared with the trimer and tetramer, in agreement with
the fact that it is the same protomers that makes up the
ring (Fig. 2 B). Here we compare the shape of the p(r) func-
tions of the three studied oligomers. The local curve maxima
at ~30A˚ is conserved between the SAXS data of all three
molecules (see overlay) and reflects the shortest dimension
the ‘‘thickness’’ of the ring-like structure. As all three stud-
ied polymer stem arrangements of the same protomer (vary-
ing number), the thickness thus reflects the width of theBiophysical Journal 107(8) 1905–1912single protomer. In the sentence we thus state that the sim-
ilarity of the p(r) function at 30A˚ is in agreement with the
fact that all studied oligomers are built from the same
similar sized building block. The average ab initio model
and subsequent rigid-body modeling revealed an overall
circular shape comparable to the tetramer with a bulge
attached to the ring (Figs. 2 C and 3 C). Interestingly, the
rigid-body model suggests that although the ring is now a
five-membered polymer, the molecule adopts a quaternary
structure not so distant from the tetramer (Fig. S4). This
forces the fifth monomer to be inserted between monomer
numbers 4 and 1, and to be twisted out of the plane of the
ring to accommodate the head-to-tail restraint. It should
be noted that the pentamer SAXS data allow for more
conformational variation among the pentamer rigid-body
models, as also observed with the larger space of the pen-
tamer envelope that is not filled by the most representative
rigid-body model (Fig. 3 C). In summary, the pentamer
data further extend the conclusions drawn from the trimer
and tetramer data, all of which support a common Z-a1AT
polymerization mechanism.DISCUSSION
The C-terminal domain-swap mechanism of in vivo Z-a1AT
polymerization is based on disulphide trapping experiments
and the crystal structure of the trimer (39). Our SAXS solu-
tion structure of the Z-a1AT trimer is very similar to the
crystal structure (Fig. S3), but whereas the crystal structure
is a near-perfect planar molecule with a 3-fold rotation axis,
our trimer model forms a slightly more compact, elongated
triangle. This small difference may be a consequence of
the low resolution of the structural information obtained
with the SAXS method or it may signify a higher flexibility
of the trimer in solution than in the protein crystal. None-
theless, our data support the C-terminal domain-swap mech-
anism observed in the crystallized polymer and the
disulphide trapping experiments. Moreover, the SAXS
data provide the first (to our knowledge) structural evidence
that the C-terminal domain-swap mechanism is also used in
larger a1AT polymers produced by misfolding due to the
presence of the Z mutation, and not by in vitro methods
(e.g., by heating or addition of GnHCl).
Based on our well-defined circular ab initio envelope rep-
resenting the quaternary structure of the tetramer in solu-
tion, we have no doubt that the overall structure can only
stem from an end-to-end closure of the polymer strand. A
linear tetrameric polymer has a scattering quite different
from that of a ring-like structure; furthermore, the p(r) func-
tion does not resemble that of an elongated structure
(52,53). In a recent modeling study (54), it was proposed
that the loop-sheet mechanism does not allow the formation
of smaller cyclic polymers due to the rigidity of its chain
of staggered protomers. Although our SAXS data allow us
to exclude a mechanism involving loop-sheet polymer
Z-a1AT Polymers in Solution 1911formation, as the linkers between loop-sheet connected
polymer units are too short and orientated in a way that
does not allow for a closed trimer to form, the SAXS method
alone cannot distinguish between the two proposed domain-
swap mechanisms (Fig. 1,D and E). In 2011, it was convinc-
ingly shown by disulphide-linking experiments (23) that
small polymers of Z-a1AT form in vivo by insertion of a
portion of the C-terminus into a neighboring molecule. In
contrast to the s4A/5A domain-swap mechanism, this mech-
anism was characterized by the absence of dimers. Our
SAXS data on in-vivo-formed Z-a1AT polymers show
that the shape of the trimer and the larger oligomers agrees
with the C-terminal domain-swap polymerization mecha-
nism leading to the formation of self-terminating and stable
polymers.
We observe an increase in the degrees of freedom as the
self-terminating Z-a1AT polymer becomes longer. The
trimer exhibits a near-perfect triangular shape and the
tetramer forms a near-perfect circular shape. The pentamer
forms an even more flexible and voluminous envelope
(Fig. 3 C), which hints at the existence of a mix of planar,
twisted conformations. Moreover, there is some similarity
between the overall shapes of the tetramer and pentamer
(Figs. 3, B and C, and S4), suggesting that a ring-like feature
of four molecules may be a favorable overall quaternary
structure of the polymers, due to minimal steric clashes be-
tween the individual monomers. This is supported by native
PAGE of unfractionated polymers, where the tetramer ap-
pears to be the most abundant polymer to form (i.e., with
the strongest band density; Fig. 4).FIGURE 4 Native PAGE of purified oligomers. Mixed short Z-a1AT
polymers (lane 1) were purified from Pichia pastoris cells initially by nickel
affinity (IMAC) and subsequently separated from monomer and large poly-
mers by Q-Sepharose chromatography. Individual oligomeric species were
separated by size-exclusion chromatography through repeated runs on a
Superdex 200 column (GE Healthcare). Purified trimer (lane 2), tetramer
(lane 3), and pentamer (lane 4) are shown. The slight variation in the posi-
tion of purified oligomer bands (lanes 2–4) compared with the correspond-
ing bands in the mixed polymers (lane 1) may be due to protein loading
differences or to the fact that the N-terminus of a1AT protomers can be sus-
ceptible to proteolysis. To see this figure in color, go online.In conclusion, our SAXS data support the proposed C-ter-
minal domain-swap mechanism of self-terminating poly-
merization of Z-a1AT in vivo. We propose that Z-a1AT
oligomers in vivo most likely extend to even higher-order
polymers (cyclic and linear) by a common mechanism, as
observed for the trimer in the crystal structure (see sche-
matic drawings in Fig. 3). Furthermore, our low-resolution
data confirm that the crystallographic trimer represents a
valid model of the Z-a1AT trimer in solution. In this
study, we generated the first (to our knowledge) solution
structures of larger serpin polymers and expanded the cur-
rent knowledge about the process of Z-a1AT polymeriza-
tion. This deeper understanding of serpin polymerization
may contribute to the development of ways to control or
hinder the pathology associated with in vivo accumulation.SUPPORTING MATERIAL
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